GB0220996D0 - Active/polymer coformulations - Google Patents
Active/polymer coformulationsInfo
- Publication number
- GB0220996D0 GB0220996D0 GBGB0220996.3A GB0220996A GB0220996D0 GB 0220996 D0 GB0220996 D0 GB 0220996D0 GB 0220996 A GB0220996 A GB 0220996A GB 0220996 D0 GB0220996 D0 GB 0220996D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- coformulations
- polymer
- active
- polymer coformulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
- B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9920558.5A GB9920558D0 (en) | 1999-08-31 | 1999-08-31 | Methods for particle formation and their products |
GB0021227A GB2355194B (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0220996D0 true GB0220996D0 (en) | 2002-10-23 |
GB2381453A GB2381453A (en) | 2003-05-07 |
GB2381453A8 GB2381453A8 (en) | 2003-06-30 |
Family
ID=26244930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0220996A Withdrawn GB2381453A (en) | 1999-08-31 | 2000-08-31 | Active/polymer coformulations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2381453A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113226942A (en) * | 2018-12-28 | 2021-08-06 | 株式会社可乐丽 | Water-soluble film and package |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
IE75744B1 (en) * | 1995-04-03 | 1997-09-24 | Elan Corp Plc | Controlled release biodegradable micro- and nanospheres containing cyclosporin |
US5980942A (en) * | 1997-01-23 | 1999-11-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release matrix tablet formulations of carbamazepine |
DE19821951A1 (en) * | 1998-05-15 | 1999-11-18 | Basf Ag | Orally administered solid or liquid cyclosporin compositions |
IL145140A0 (en) * | 1999-03-24 | 2002-06-30 | Fmc Corp | Improved aqueous solubility pharmaceutical formulations |
-
2000
- 2000-08-31 GB GB0220996A patent/GB2381453A/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113226942A (en) * | 2018-12-28 | 2021-08-06 | 株式会社可乐丽 | Water-soluble film and package |
CN113226942B (en) * | 2018-12-28 | 2023-05-02 | 株式会社可乐丽 | Water-soluble film and package |
Also Published As
Publication number | Publication date |
---|---|
GB2381453A8 (en) | 2003-06-30 |
GB2381453A (en) | 2003-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24226A (en) | Formulation | |
GB9920774D0 (en) | Polymer | |
HUP0201795A2 (en) | Disinfectants | |
GB9905898D0 (en) | Controlled-dose formulation | |
GB9902304D0 (en) | Formulation | |
HUP0105229A3 (en) | Fungicidal active substance combinations | |
GB2356125B (en) | Ensilage | |
GB9927715D0 (en) | Hollow-needle devices | |
GB9923816D0 (en) | Polymeric surfactants | |
GB0220996D0 (en) | Active/polymer coformulations | |
GB9927614D0 (en) | Sterliant formulation | |
GB2356478B (en) | Card-marking devices | |
DE60022447D1 (en) | Optisch aktive polythiophene | |
GB9907686D0 (en) | Charlotte | |
GB9902236D0 (en) | Formulation | |
GB9908687D0 (en) | Active PZT | |
GB9905060D0 (en) | The saboteur | |
GB9917608D0 (en) | Activity device | |
GB9927714D0 (en) | Hollow-needle devices | |
GB9921571D0 (en) | My complmentry | |
GB9930392D0 (en) | Substances | |
GB9901087D0 (en) | Lasing device | |
GB9923538D0 (en) | Formulation | |
GB9908776D0 (en) | Formulation | |
GB9902089D0 (en) | Formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |